Clinical Trial Update: Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating raloxifene for schizophrenia and schizoaffective disorder; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: Sheba Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: UNKNOWN